A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice

Journal of Pain

Volumn 11, Issue 2, 2010, Pages 149-159

  Galeotti, Nicoletta ^a   Vivoli, Elisa ^a   Bilia, Anna Rita ^a   Bergonzi, Maria Camilla ^a   Bartolini, Alessandro ^a   Ghelardini, Carla ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

analgesia; antinociception; hyperforin; hypericin; Hypericum perforatum; St. John's Wort

Indexed keywords

13,118 BIAPIGENIN; ADHYPERFORIN; FLAVONOID; FUROHYPERFORIN; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; HYPERIN; ISOQUERCITRIN; NAPHTHODIANTHRONE DERIVATIVE; OPIATE RECEPTOR; OXIHYPERFORIN; PHLOROGLUCINOL DERIVATIVE; PROTEIN KINASE C; PSEUDOHYPERICIN; QUERCETIN; QUERCITRIN; RUTOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PAIN;

ACETIC ACID; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG COMPOUNDING; HYPERICUM; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PERYLENE; PHORBOL ESTERS; PHYTOTHERAPY; PROTEIN KINASE C; QUERCETIN; SOMATOSTATIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 75749136006     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2009.06.013     Document Type: Article

References (36)

1. Agostinis P., Vantieghem A., Merlevede W., and de Witte P.A. Hypericin in cancer treatment: More light on the way. Int J Biochem Cell Biol 34 (2002) 221-241
2. Barnes J., Anderwson L.A., and Phillipson D.J. St. John's wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53 (2001) 583-600
3. Bergonzi M.C., Bilia A.R., Gallori S., Guerrini D., and Vincieri F.F. Variability in the content of the constituents of Hypericum perforatum L. and some commercial extracts. Drug Dev Ind Pharm 27 (2001) 491-497
4. Bighetti E.J.B., Hiruma-Lima C.A., Gracioso J.S., and Souza Brito A.R.M. Anti-inflammatory and antinociceptive effects in rodents of the essential oil of Croton cajucara Benth. J Pharm Pharmacol 51 (1999) 1447-1453
5. Bilia A.R., Gallori S., and Vincieri F.F. St. John's wort and depression: Efficacy, safety and tolerability - an update. Life Sci 70 (2002) 3077-3096
6. Bombardelli E., and Morazzoni P. Hypericum perforatum. Fitoterapia 66 (1995) 43-68
7. Brolis M., Gabetta B., Fuzzati N., Pace R., Panzeri F., and Peterlongo F. Identification by high performance liquid chromatography-diode array detection-mass spectrometry and quantification by high performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. J Chromatogr A 825 (1998) 9-16
8. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., and Muller W.E. Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci 63 (1998) 499-510
9. Chatterjee S.S., Noldner M., Koch E., and Erdelmeier C. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 31 Suppl 1 (1998) 7-15
10. Collier H.O.J., Dinneen L.C., Johnson C.A., and Schnider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 32 (1968) 295-310
11. Ferriola P.C., Cody V., and Middleton Jr. E. Protein kinase C inhibition by plant flavonoids. Biochem Pharmacol 38 (1989) 1617-1624
12. Fiebich B.L., Hollig A., and Lieb K. Inhibition of substance P-induced cytokine synthesis by St. John's Wort extracts. Pharmacopsychiatry 34 Suppl 1 (2001) S26-S28
13. Galeotti N., Bartolini A., and Ghelardini C. The phospholipase C-IP3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology 28 (2003) 888-897
14. Gobbi M., Dalla Valle F., Ciapparelli C., Diomede L., Morazzoni P., Verotta L., Caccia S., Cervo L., and Mennini T. Hypericum perforatum L. extract does not inhibit 5-HT transporter in the rat brain. N.-S Arch Pharmacol 360 (1999) 262-269
15. Greeson J.M., Sanford B., and Monti D.A. St, John's wort (Hypericum perforatum): A review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology 153 (2001) 402-414
16. Gulya K., Krivan M., Nyolczas N., Sarnyai Z., and Kovacs G.L. Central effects of the potent and highly selective μ opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice. Eur J Pharmacol 150 (1988) 355-360
17. Hammer K., Hillwig M.L., Solco A.K., Dixon P.M., Delate K., Murphy P.A., Wurtele E.S., and Birt D.F. Inhibition of prostaglandin E2 production by anti-inflammatory Hypericum perforatum extracts in RAW264.7 mouse macrophage cells. J Agric Food Chem 55 (2007) 7323-7331
18. Horan P., Taylor J., Yamamura H.I., and Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail flick test. J Pharmacol Exp Ther 260 (1992) 1237-1243
19. Isacchi B., Galeotti N., Bergonzi M.C., Ghelardini C., Bilia A.R., and Vincieri F.F. Pharmacological in vivo test to evaluate the bioavailability of some St. John's Wort innovative oral preparations. Phytother Res 23 (2009) 197-205
20. Kubin A., Wierrani F., Burner U., Alth G., and Grünberger W. Hypericin - The facts about a controversial agent. Curr Pharmac Des 11 (2005) 233-253
21. Linde K, Mulrow CD, Berner M, Egger M: St John's wort for depression. Cochrane Database Syst Rev 2:CD000448, 2005
22. Mattace Raso G., Pacilio M., Di Carlo G., Esposito E., Pinto L., and Meli R. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 54 (2002) 1379-1383
23. Medina M.A., Martínez-Poveda B., Amores-Sánchez M.I., and Quesada A.R. Hyperforin: More than an antidepressant bioactive compound?. Life Sci 79 (2006) 105-111
24. Meotti F.C., Luiz A.P., Pizzolatti M.G., Kassuya C.A.L., Calixto J.B., and Santos A.R. Analysis of the antinociceptive effect of the flavonoid myricitrin: Evidence for a role of the L-arginine nitric-oxide and protein kinase C pathways. J Pharmacol Exp Ther 316 (2006) 789-796
25. Muller W.E., Singer E., Wonnemann M., Hafner U., Rolli M., and Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31 Suppl 1 (1998) 16-21
26. Portoghese P.S., Sultana M., Nagase H., and Takemori A.E. A highly selective δ1-opiod receptor antagonist: 7-benzylidenenaltrexone. Eur J Pharmacol 218 (1992) 195-196
27. Simmen U., Higelin J., Berger-Büter K., Schaffner W., and Lundstrom K. Neurochemical studies with St. John's Wort in vitro. Pharmacopsychiatry 34 Suppl 1 (2001) S137-S142
28. Simmen U., Schweitzer C., Burkard W., Schaffner W., and Lundstrom K. Hypericum perforatum inhibits the binding of mu- and kappa-opioid receptor expressed with the Semliki Forest virus system. Pharm Acta Helv 73 (1998) 53-56
29. Sofuoglu M., Portoghese P.S., and Takemori A.E. Differential antagonism of δ opioid agonists by naltrindone and its benzofuran analog (NTB) in mice. Evidence for δ opioid receptor subtypes. J Pharmacol Exp Ther 257 (1991) 676-680
30. Sosa S., Pace R., Bornancin A., Morazzoni P., Riva A., Tubaro A., and Della Loggia R. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J Pharm Pharmacol 59 (2007) 703-709
31. Srinivasan K., Muruganandan S., Lal J., Chandra S., Tandan S.K., Raviprakash V., and Kumar D. Antinociceptive and antipyretic activities of Pongamia pinnata leaves. Phytother Res 17 (2003) 259-264
32. Suzuki O., Katsumata Y., Oya M., Bladt S., and Wagner H. Inhibition of monoamine oxidase by hypericin. Planta Med 50 (1984) 272-274
33. Takahashi I., Nakanishi S., Kobayashi E., Nakano H., Suzuki K., and Tamaoki T. Hypericin and pseudohypericin specifically inhibit protein kinase C: Possible relation to their antiretroviral activity. Biochem Biophys Res Commun 165 (1989) 1207-1212
34. Tedeschi E., Menegazi M., Margotto D., Suzuki H., Forstermann U., and Kleinert H. Antiinflammatory actions of St. John's wort: Inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1 alpha) activation. J Pharmacol Exp Ther 307 (2003) 54-261
35. Uchida S., Hirai K., Hatanaka J., Hanato J., Umegaki K., and Yamada S. Antinociceptive effects of St. John's Wort, Harpagophytum Procumbens extract and grape seed proantocyanidins extract in mice. Biol Pharm Bull 31 (2008) 240-245
36. Velàzquez K.T., Mohammad H., and Sweitzer S.M. Protein kinase C in pain: Involvement of multiple isoforms. Pharmacol Res 55 (2007) 578-589